SCHEMBL3760211

SCHEMBL3760211

C=CC(=O)/[C]=C\CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760214 1.00
SCHEMBL27467419 0.70
SCHEMBL503574 0.70
SCHEMBL16044216 0.70
SCHEMBL10840917 0.70
Acrylic Acid SCHEMBL30431258 0.66 LMNA (0.71)
Acrylic Acid SCHEMBL27615806 0.66 LMNA (0.71)
Acrylic Acid SCHEMBL1147986 0.66
Acrylic Acid SCHEMBL6557843 0.66 LMNA (0.71)
Acrylic Acid SCHEMBL29502206 0.66 LMNA (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268825-B2 Method for the treatment of anthrax infections THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) 2012-09-18 US disclosed
US-20100305119-A1 Method for the treatment of anthrax infections NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-12-02 US disclosed
EP-0966464-B1 SUBSTITUTED 2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2003-05-28 EP disclosed
US-6114330-A BACTERICIDES HOFFMANN-LA ROCHE INC. (US) 2000-09-05 US disclosed
EP-0966464-A1 SUBSTITUTED 2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 1999-12-29 EP disclosed
WO-1998039328-A1 SUBSTITUTED 2,4-DIAMINOPYRIMIDINES F.HOFFMANN-LA ROCHE AG (CH) 1998-09-11 WO disclosed